536565
TRIMURTHI
Start SIP
Invest Now
Start SIP in TRIMURTHI
Performance
- Low
- ₹53
- High
- ₹55
- 52 Week Low
- ₹24
- 52 Week High
- ₹70
- Open Price₹54
- Previous Close₹53
- Volume14,111
- 50 DMA₹56.63
- 100 DMA₹51.71
- 200 DMA₹42.70
Investment Returns
- Over 1 Month -11.32%
- Over 3 Month + 20.84%
- Over 6 Month + 13.8%
- Over 1 Year + 120.91%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 88.7
- PEG Ratio
- 0
- Market Cap Cr
- 86
- P/B Ratio
- 3.2
- Average True Range
- 3.35
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0
- RSI
- 41.23
- MFI
- 52.93
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
Current Price
₹53.35
+
0.46
(0.87%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹57.86
- 50 Day
- ₹56.63
- 100 Day
- ₹51.71
- 200 Day
- ₹42.70
Resistance and Support
54.09
- R3 58.59
- R2 57.02
- R1 55.66
- S1 52.73
- S2 51.16
- S3 49.80
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & A.G.M. | |
| 2025-06-24 | Others | Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company. |
| 2025-05-27 | Audited Results | |
| 2025-04-12 | Others | Inter-alia, to consider 1. Convening of an EGM for appointment of Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for the upcoming EGM. 3. Other business matters. |
Novelix Pharmaceuticals F&O
About Novelix Pharmaceuticals
- NSE Symbol
- TRIMURTHI
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹53 As on 19 January, 2026 | 08:58
The Market Cap of Novelix Pharmaceuticals is ₹86.1 Cr As on 19 January, 2026 | 08:58
The P/E ratio of Novelix Pharmaceuticals is 88.7 As on 19 January, 2026 | 08:58
The PB ratio of Novelix Pharmaceuticals is 3.2 As on 19 January, 2026 | 08:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.